A multifaceted intervention in support of diabetes treatment guidelines: a cont trial.

Division of Metabolism, Endocrinology and Nutrition, University of Washington School of Medicine, 1959 NE Pacific Street, Box 356176, Seattle, WA 98195, USA.
Diabetes Research and Clinical Practice (Impact Factor: 2.74). 11/2002; 58(1):27-36. DOI: 10.1016/S0168-8227(02)00100-6
Source: PubMed

ABSTRACT in an academic family practice clinic, we performed a controlled trial of a multifaceted intervention versus usual care for managing diabetes. Providers received didactic training and computerized compliance feedback to support staged diabetes management, an evidenced-based approach to diabetes care.
one firm of the clinic practice received the intervention, the other served as the control group during a 14-month baseline period and a 14-month study period. HbA1(c) was the principal outcome measure.
there was a significant 0.71% difference in change in HbA1(c) values between the intervention and control firms (P=0.02). The subgroup with the greatest improvement in HbA1(c) was those subjects who started the intervention with a HbA1(c) above 8%. The overall improvement in glycemic control could not be explained by differences in visit frequency or the aggressiveness of drug therapy. There were no changes in healthcare utilization or costs between the two firms.
in an academic family practice clinic, a multifaceted intervention in support of diabetes treatment guidelines modestly improved glycemic control without incurring additional costs. The improvement was mostly due to mitigation of the natural deterioration in control usually seen. Further efforts are required to involve all patients in co-managing their diabetes.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: This systematic review and meta-analysis aims at assessing the composition and performance of care management models evaluated in the last decade and their impact on patient important outcomes. A comprehensive literature search of electronic bibliographic databases was performed to identify care management trials in type 2 diabetes. Random effects meta-analysis was used when feasible to pool outcome measures. Fifty-two studies were eligible. Most commonly reported were surrogate outcomes (such as HbA1c and LDL), followed by process measures (clinic visit or testing frequency). Less frequently reported were quality of life, patient satisfaction, self-care, and healthcare utilization. Most care management modalities were carved out from primary care. Meta-analysis demonstrated a statistically significant but trivial reduction of HbA1c (weighted difference in means -0.21%, 95% confidence interval -0.40 to -0.03, p < .03) and LDL-cholesterol (weighted difference in means -3.38 mg/dL, 95% confidence interval -6.27 to -0.49, p < .02). Most care management programs for patients with type 2 diabetes are 'carved-out', accomplish limited effects on metabolic outcomes, and have unknown effects on patient important outcomes. Comparative effectiveness research of different models of care management is needed to inform the design of medical homes for patients with chronic conditions.
    BMC Health Services Research 03/2012; 12:72. · 1.77 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A tactile hearing aid was modified to test the ability of lateral inhibition to sharpen the perceived tactile display. The aid was based on amplitude- and time-quantized speech. The digital frequencies in the processes signal were detected and displayed via a linear array of electrodes using biphasic constant current pulses. In the lateral inhibition scheme the active electrode inhibits other electrodes that are plus or minus three electrodes away from it. Inhibition and no-inhibition schemes were tested with the two schemes in a forced choice test. No statistically significant difference could be detected between the two display schemes for the test material
  • [Show abstract] [Hide abstract]
    ABSTRACT: Cleveringa FGW, Gorter KJ, Van den Donk M, Rutten GEHM. Het Diabetes Zorg Protocol. Huisarts Wet 2011;54(5):248–52. Het Diabetes Zorg Protocol (DZP) ondersteunt het handelen volgens de NHG-Standaard Diabetes mellitus type 2 met beslissingsondersteunende software, een oproepsysteem en feedback op het handelen, en door een praktijkondersteuner in te schakelen als casemanager. Het DZP verbetert het cardiovasculaire risico van patiënten met diabetes mellitus type 2. Ondanks de intensieve behandeling heeft het DZP op korte termijn geen substantiële negatieve effecten op de kwaliteit van het leven. Het DZP is kosteneffectief voor patiënten met een voorgeschiedenis met harten vaatziekten. De belangrijkste reden voor dit positieve resultaat is de combinatie van beslissingsondersteunende software met casemanagement en feedback op het handelen van de huisartsenpraktijk. Het gemiddelde HbA1c in eerstelijnsdiabetespopulaties ligt dicht bij de 7%. Verdere verlaging zal niet leiden tot minder hart- en vaatziekten. Om de diabeteszorg kosteneffectief te verbeteren, lijkt het identificeren van hoogrisicopatiënten door het berekenen van het cardiovasculaire tienjaarsrisico de eenvoudigste methode. De patiënten zullen meer zorg op maat moeten krijgen, waarbij men het totale cardiovasculaire risicoprofiel moet behandelen en niet alleen de bloedglucose. Praktijkverpleegkundigen kunnen dit niet alleen. De complexe comorbiditeit vraagt een actieve betrokkenheid van huisartsen. Met de toenemende roep om objectieve maten voor goede kwaliteit van zorg lijken intelligente informatiesystemen haast onmisbaar.
    Huisarts en wetenschap 05/2011; 54(5).

Full-text (2 Sources)

Available from
May 22, 2014